Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
Industry News
Economics
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
Forex
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
Entertainment
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Press Releases
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
Video News
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
Audio News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
 Economic Calendar
RTT DeskAlert
Font Down Font Up
 
FDA Approves Bristol-Myers' Abilify To Treat Irritabilty In Pediatric Patients With Autistic Disorder - Update
11/20/2009 7:44 PM  ET

RELATED NEWS
Bristol-Myers Squibb Gets FDA Approval To Market Abilify For Treatment Of Irritability Associated With Autistic Disorder - Quick Facts
Bristol-Myers Squibb Set New High For Year Monday
Bristol-Myers Squibb To Split-off Mead Johnson As Independent BioPharma Company - Update
Bristol-Myers Squibb To Split Off Stake In Mead Johnson Nutrition - Quick Facts
Bristol-Myers Squibb To Present At Credit Suisse Healthcare Conference; Webcast At 10:30 AM ET
TOP MARKET NEWS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Stocks Remain Stuck In The Red In Mid-Afternoon Trading - U.S Commentary
Stocks Posting Moderate Losses In Early Afternoon Trading - U.S. Commentary
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
Stocks Seeing Further Downside In Late Morning Trading - U.S. Commentary
(RTTNews) -  Friday, BMY closed at $24.46, up $0.43 or 1.79% on a volume of 24.66 million shares on NYSE. In after hours, the stock gained $0.04 or 0.16% to trade at $24.50.

Click here to receive FREE breaking news email alerts for Bristol-Myers Squibb Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com

 Previous Page   1   2 


Share Article:   Del.icio.us    Digg    Y! My Web    Facebook    My Space

Email        Print        
Comment On This Story
      

EDITOR'S PICKS
Stocks Close Mostly Lower Amid Disappointing Quarterly Results - U.S. Commentary
Senate Democrats Fault GOP For Failing To Advance Alternative Health Reforms
New Guidelines Recommend Women Wait Until 21 For Cervical Cancer Screening
House Passes Bill To Stop Reduction In Medicare Payments To Doctors
Intuit Posts Wider Loss In Q1, Guides Q2, Backs FY10 Forecast
Gap Q3 Profit Rises 25%; To Buyback $500 Mln Shares
Nokia To Cut Up To 330 Jobs In R&D - Update
Dell Q3 Profit Drops 54%
Belgian Prime Minister Herman Van Rompuy Named First EU President
Fed's Fisher: "Too-Big-To-Fail" Must Be Addressed

MOST READ
Silver Wheaton Shines - Stocks To Watch
Belgian Prime Minister Herman Van Rompuy Named First EU President
Ron Paul's Fed Audit Proposal Passes Financial Services Committee
MasterCard Inc. Is Picking Up Volume
Centerpoint Energy Unit Signs Joint Development Deal With FPL Affiliate To Explore Construction Of New Pipeline
Sen. Gregg Calls Ron Paul's Fed Audit Amendment "Political Pandering"
Expatriate To Be Next Tata Chief?
Berkshire Hathaway Secures $8 Bln. For Burlington Northern Deal - Update
Reports: Colgate Stock Rise On Reckitt Merger Talk - Update
OECD Raises 2010 GDP Growth Outlook; Sees China Leading Global Recovery

MOST E-MAILED
House Passes Bill To Stop Reduction In Medicare Payments To Doctors
AstraZeneca Submits NDA For Ticagrelor To FDA - Quick Facts
Pakistan-based Terror Groups Plotting More Attacks: India
AstraZeneca Files NDA For Antiplatelet Treatment Brilinta - Update
Tyson Foods Promotes Donnie Smith To President, CEO - Update
Nortel To Delay Auction For Sale Of Its GSM/GSM-R Business - Quick Facts
Novavax To Offer Common Shares In Underwritten Public Offering - Quick Facts
Microvision Prices Public Offering - Quick Facts
JPMorgan To Buy Remaining Stake In Cazenove For GBP 5.35 Per Share - Update
Bank Of Smithtown Appoints John Romano As President And COO - Quick Facts
  Trading Center
 

More Breaking News-US
73  EU Extends Review Deadline For Oracle's Proposed Takeover Of Sun Micro - Update
72  Pfizer's Geodon Approved As Adjunctive For Bipolar Disorder - Update
71  CF Nominees Enter Terra's Board - Update
70  Archipelago Learning Prices IPO Within Expected Range; Stock Soars - Update
69  Brown University And IBM Launch Multimillion-Dollar Supercomputer - Update
68  GLG Life Tech Starts Trading On Nasdaq; Shares Down 13.7% - Update
67  Global Defense Technology Prices IPO At $13/Share, Below Prior Estimate - Update
66  Dendreon Gets FDA Acceptance For Prostrate Cancer Drug Application - Update
65  Covidien's Pain Drug NDA Review Extended By FDA - Update
64  Inovio's Pre-clinincal Study Of Universal Flu Vaccines Reports Protective Response Against Multiple Influenza Strains; Stock Up - Update
63  Cloud Peak Energy Prices IPO At $15/shr - Update
62  Met-Pro Q3 Profit Plunges - Update
61  Boston Scientific Receives FDA's 510 (k)Clearance For WallFlex Fully Covered Esophageal Stent - Update
60  Pfizer Granted FDA Approval For Intravenous Formulation Of Revatio - Update
59  Berkshire Hathaway Secures $8 Bln. For Burlington Northern Deal - Update
  

 
Copyright © 2009 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service | How To Use RTTNews.com| Advertise| Buy Content | RSS